I feel like this is @haroldpollack goal when teaching Econ
My favorite student eval from this past semester: "The class did not have the most thrilling content so I think she did the best that she could" 💀
1
2
466
I have also saved a turtle during a run, so I am basically the same as @des_linden
5
Mary retweeted
The author makes good argument that we can’t stop at insulin in constraining prices of life-saving diabetes drugs. Of course keeping insulin prices high to encourage more-powerful medication use is not the right way to address the challenges he considers. theatlantic.com/health/archi…
There are better ways to address the author’s @MikeRoseMDMPH concerns than by keeping the price of life saving insulin high. I have diabetes. I also have a good job with good insurance. Still have gone into debt to pay for diabetes care.
Laws that make insulin cheaper for patients are a great idea. But in their current version, they could lead to even more diabetes-related deaths overall, @MikeRoseMDMPH writes. theatlantic.com/health/archi…
1
When @haroldpollack travels…
Mary retweeted
No. Demand for insulin is price-inelastic. Human bodies need the amount of insulin they need. Biology doesn’t care about prices.
…and it’s been a quarter century since there’s been much significant innovation.
In case @arrpeeoh needs a birthday gift for me…
COVER REVEAL AND EXCERPT! Get ready for NINE LIARS, coming December 27th!
usatoday.com/story/entertain…
So excited to see this work by colleagues from @UChiUrbanLabs
A study from the University of Chicago took 18 months to look at the way the nation's 911 centers operate and has resulted in a list of recommendations to improve the system. wgntv.com/morning-news/new-s…
Thrilled to have a poster @AcademyHealth with my @UChiUrbanLabs @jcoinctc ROMI colleagues. Now to convince @arrpeeoh to let me hang it up in our house once back home…
Really bummed that there wasn’t an all inclusive pass to cover both conferences. #ARM22 #academyhealth #AwesomeCon2022
I helped write a thing!
“Social work is a neglected stepchild of American health policy practice and discourse” write authors @haroldpollack @jd_lerner & Mary Beth Shapley of @UChiUrbanLabs in the latest Milbank Quarterly Opinion. A rebuke to health policy colleagues and peers buff.ly/3lBaBBD
1
Interests of people w/ diabetes can’t truly be served by advocacy orgs who are funded by drug companies. #type1diabetes #type1lookslikeme #Insulin4all
One in two people worldwide who need insulin can’t properly access it. But the two biggest American diabetes nonprofits take millions annually from insulin manufacturers — a conflict of interest that is hurting people with diabetes. jacobinmag.com/2022/04/diabe…
Enjoying a quantity of pizza and insulin to celebrate pi day and a successful site visit with colleagues from @UChiUrbanLabs and @uicpublichealth
I can do this thanks to @GaryScheiner and his amazing “how to bolus for pizza” video.
Mary retweeted
if you're having a shitty time with your mental health and are low functioning i feel u & sympathise. here's a list of potential actions for u to take to feel better/exist through it. try to pick a few & do them, but if you can't : that's valid too. let's go
THIS. Redesivir is an inpatient drug. But people who don’t work in healthcare might not have good understanding of what payment based on DRG means.
I’m confused by this phrasing and people’s concern on Twitter.
If this is an inpatient drug, Medicare and Medicaid aren’t paying for it — the hospitals are.
So Gilead isn’t “charging” Medicare anything and when the government is the purchaser it is paying the government price.
1




















